APA (7th ed.) Citation

Li, Y., Qian, J., Dong, X., Zhao, J., Wang, Q., Wang, Y., . . . Li, M. (2024). The prognosis and management of reclassified systemic lupus erythematosus associated pulmonary arterial hypertension according to 2022 ESC/ERS guidelines. Arthritis research & therapy, 26(1), 109-8. https://doi.org/10.1186/s13075-024-03338-1

Chicago Style (17th ed.) Citation

Li, Yutong, Junyan Qian, Xingbei Dong, Jiuliang Zhao, Qian Wang, Yanhong Wang, Xiaofeng Zeng, Zhuang Tian, and Mengtao Li. "The Prognosis and Management of Reclassified Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension According to 2022 ESC/ERS Guidelines." Arthritis Research & Therapy 26, no. 1 (2024): 109-8. https://doi.org/10.1186/s13075-024-03338-1.

MLA (9th ed.) Citation

Li, Yutong, et al. "The Prognosis and Management of Reclassified Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension According to 2022 ESC/ERS Guidelines." Arthritis Research & Therapy, vol. 26, no. 1, 2024, pp. 109-8, https://doi.org/10.1186/s13075-024-03338-1.